XOLAIR - omalizumab
Navigation: NDC > Supplier starting with: G > GENENTECH, INC.| Field | Value |
|---|---|
| NDC Code: | 50242-040 |
| Proprietary Name: | XOLAIR |
| Suffix: | |
| Non-Proprietary Name: | omalizumab |
| Dosage Form: | INJECTION, SOLUTION |
| Method: | SUBCUTANEOUS |
| Original Marketing Date: | 20-06-2003 |
| Category Name: | BLA |
| Application Number: | BLA103976 |
| Labeler: | GENENTECH, INC. |
| Substance Name: | OMALIZUMAB |
| Active Numerator Strength: | 202.5 |
| Active Ingredient Unit: | mg/1.4mL |
| Pharm Classes: | Anti-IgE [EPC],Decreased IgE Activity [PE],IgE-directed Antibody Interactions [MoA] |
| DEA Schedule: |